TransCelerate BioPharma will be in attendance and represented by the following speakers:
Tuesday, February 18
- 12:05 PM: Change Management Clinical Supply Chain Considerations for Digitally Enabled Patient-Centric Clinical Trials, Matthew Moyer (Merck)
Wednesday, February 19
- 11:35 AM: An Exploration of Effective Regulator Engagement Regarding the Use of Digital Endpoints Suraj Ramachandran (Merck)
- 2:20 PM Strengthening Your Clinical QMS: A Focus on Clinical Development Processes and Associated Documentation and Training, Odette Anyangwe (Roche)
- 2:24 PM: The Application of Quality Tolerance Limits (QTLs) as Described in ICH E6 R2, Ruma Bhagat (Genetech)
- 4:25 PM: How Can We Improve the Patient Experience in Clinical Trials? T.J. Sharpe; Michele Teufel (AstraZeneca)
Thursday, February 20
- 8:25 AM: Engaging with Patients in Design and Execution of Trials: Ways to Make Clinical Trials More Patient-Centric, David Leventhal (Pfizer)
- 9:05 AM: Quality Risk Management Framework: Guidance for Successful Implementation of Risk Management in Clinical Development, Allan Chow (Amgen)
Friday, February 21
- 9:35 AM: The Application of Intelligent Automation Technologies in Pharmacovigilance,
Robert Taylor (Merck) - 11:00 AM: Assessing Your Clinical Quality Management System: A Comprehensive Review of TransCelerate’s CQMS Assessment Tool, Janis Little (Allergan)